ReviewCurrent infectious disease reports2017
The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century.
Review in Current infectious disease reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
100 citing papers in PubMed, 4 syntheses or guidelines pooled it, 215 citations in OpenAlex.
- EANM/SNMMI guideline/procedure standard for [European journal of nuclear medicine and molecular imaging · 2025Guideline
- A comparison of different antibiotic regimens for the treatment of infective endocarditis.The Cochrane database of systematic reviews · 2020Pooled it
- Pooled it
- Epidemiology of infective endocarditis beforeTherapeutic advances in cardiovascular diseasePooled it
- Infective Endocarditis in Ireland: A Nationwide Analysis.Journal of clinical medicine · 2026Article
- Infective endocarditis in a university hospital without on-site cardiac surgery: temporal trends over 37 years.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Infective endocarditis treated surgically: correlation between imaging, and surgical findings.The international journal of cardiovascular imaging · 2026Article
- Health-Related Quality of Life of Patients With Infective Endocarditis-A Cross-Sectional Study Based on Data From the DERIVE Cohort.Open forum infectious diseases · 2026Article
- Focusing on persistent hypoxemia during VV-ECMO secondary to traumatic tricuspid valve injury: a case report.Frontiers in medicine · 2026Article
- Indicators of In-Hospital Mortality in Infective Endocarditis: A Single-Center Retrospective Study.Cureus · 2026Article
- Infective Endocarditis in a Tertiary Hospital in Porto-Is There Anything New?Infectious disease reports · 2025Article
- Trends in Epidemiology, Clinical Characteristics, and Outcomes of Infective Endocarditis: A 16-Year Nationwide Cohort Study in Korea.Journal of Korean medical science · 2025Article
- The Evolving Risk of Infective Endocarditis After Transcatheter Aortic Valve Implantation.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025Article
- Prosthetic Aortic Valve Endocarditis Caused by Burkholderia cepacia complex: A Case Report.Cureus · 2025Article
- Epidemiology of community acquired and health care assocİated infective endocarditis and 28 day mortality risk factors: a university hospital study.BMC infectious diseases · 2025Article
- Epidemiological, clinical and microbiological aspects of infective endocarditis in Türkiye.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Article
- Embolic complications in a large contemporary cohort of infective endocarditis: do we need score model?Infection · 2025Observational
- Cardiac Device-related Infective Endocarditis and Retrosternal Abscess Treated with Percutaneous Lead Extraction and Antimicrobials.Internal medicine (Tokyo, Japan) · 2025Article
- Incidence rate of infective endocarditis by socioeconomic position: a Danish nationwide cohort study (2000-2022).The Lancet regional health. Europe · 2025Article
- Economic burden of infective endocarditis in Zhejiang region from 2007 to 2016.BMC infectious diseases · 2025Article
40 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of the reviewInfective endocarditis (IE) is a relatively infrequent infectious disease. It does, however, causes serious morbidity, and its mortality rate has remained unchanged at approximately 25%. Changes in IE risk factors have deeply impacted its epidemiology during recent decades but literature from low-income countries is very scarce. Moreover, prophylaxis guidelines have recently changed and the impact on IE incidence is still unknown. RECENT
findingsIn high-income countries, the proportion of IE related to prior rheumatic disease has decreased significantly and has been replaced proportionally by cases related to degenerative valvulopathies, prosthetic valves, and cardiovascular implantable electronic devices. Nosocomial and non-nosocomial-acquired cases have risen, as has the proportion caused by staphylococci, and the median age of patients. In low-income countries, in contrast, rheumatic disease remains the main risk factor, and streptococci the most frequent causative agents. Studies performed to evaluate impact of guidelines changes' have shown contradictory results. The increased complexity of cases in high-income countries has led to the creation of IE teams, involving several specialties. New imaging and microbiological techniques may increase sensitivity for diagnosis and detection of IE cases. In low-income countries, IE remained related to classic risk factors. The consequences of prophylaxis guidelines changes are still undetermined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.